Article
Rapamycin rescues loss-of-function in blood-brain barrier-interacting regulatory T cells
2022-10-21
Abstract excerpt
In many autoimmune diseases, FOXP3 + regulatory T cells (Tregs) skew towards a pro-inflammatory and non-suppressive phenotype and are therefore unable to control the exaggerated autoimmune response. This may largely impact the success of autologous Treg therapy which is currently under investigation for treatment of autoimmune diseases, including multiple sclerosis (MS). Thus, there is a need to ensure in vivo s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 81102a93-5cab-551a-b09f-7680145286b0
- DOI
- 10.1101/2022.10.21.513147
